Fact Based List:

Vizient: Top 10 drugs by Total Spend Among Members

  1. Adalimumab (Humira)
  2. Rituximab (Rituxan)
  3. Infliximab (Remicade)
  4. Pembrolizumab (Keytruda)
  5. Etanercept (Enbrel)
  6. Ustekinumab (Stelara)
  7. Nivolumab (Opdivo)
  8. Pegfilgrastim (Neulasta)
  9. Alteplase (Activase, Cathflo)
  10. Denosumab (Prolia, Xgeva)

Source: Vizient, January 2020
Source URL: https://www.vizientinc.com/-/media/documents/sitecorepublish...
Notes: Based on Vizient member data for October 1, 2018 through September 30, 2019.